Afuddin is a new drug for the treatment of AIDS, which is jointly developed by Henan Normal University, Zhengzhou University and Henan Analysis and Testing Research Center. It was successfully developed by Professor Chang Junbiao of Zhengzhou University. It is an HIV reverse transcriptase inhibitor, which belongs to the world's advanced and domestic first-generation drug for treating AIDS. Afuddin tablets have become the first self-developed oral small molecule COVID-19 drug in China, which needs to be used under the guidance of a doctor.
Pre-clinical research shows that compared with the existing anti-AIDS drugs, afudin can block the mutated HIV more effectively, which has the obvious advantages of low drug resistance and high curative effect.
Product advantages:
1, the dosage is small. At present, (20 13) drugs for AIDS generally need 100 ~ 200mg per day, while afuddin only needs 1mg per day.
2. International innovative drugs. At present (20 13), the drugs used in China are all generic drugs that are allowed to be produced domestically abroad. Afuddin is an international innovative drug, and its international patent has entered the United States, Europe, Japan and other countries and regions through PCT.
3. Save the cost of medicine. Because the cost of drug research and development is lower than that of foreign countries, afudin can greatly reduce the annual treatment cost of AIDS patients. ?